Evidence map›Paper›PMID 39540884›Full record

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2025

Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex.

Kris Ann P Schultz, Suzanne P MacFarland, Melissa R Perrino, Sarah G Mitchell, Junne Kamihara, Alexander T Nelson, Paige H R Mallinger, Jack J Brzezinski, Kara N Maxwell, Emma R Woodward and 13 more

Abstract readReview
In one paragraph

Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Expanding the Molecular Data ofHuman mutation · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Cancers · 2025
    Review
  17. Approach to the Pediatric Patient With Thyroid Nodules.The Journal of clinical endocrinology and metabolism · 2025
    Review
  18. Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kris Ann P SchultzInternational Pleuropulmonary Blastoma/DICER1 Registry, Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-1788-5832
Suzanne P MacFarlandDivision of Oncology, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-5894-6403
Melissa R PerrinoDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-0598-7102
Sarah G MitchellAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.ORCID 0000-0003-1656-2799
Junne KamiharaDepartment of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-2852-7387
Alexander T NelsonInternational Pleuropulmonary Blastoma/DICER1 Registry, Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-1611-4577
Paige H R MallingerInternational Pleuropulmonary Blastoma/DICER1 Registry, Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota.ORCID 0009-0001-6294-1733
Jack J BrzezinskiDivision of Haematology and Oncology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada.ORCID 0000-0002-9475-0077
Kara N MaxwellDivision of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-8192-4202
Emma R WoodwardManchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.ORCID 0000-0002-6297-2855
Bailey GallingerClinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0003-0039-3652
Sun Young KimDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, College of Medicine, University of Cincinnati, Cincinnati, Ohio.ORCID 0000-0002-9560-0652
Mary-Louise C GreerDepartment of Diagnostic and Interventional Radiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-6159-5472
Kami Wolfe SchneiderDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0003-0865-8010
Sarah R ScollonDepartment of Pediatrics, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-2017-0245
Anirban DasDivision of Haematology and Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-7653-9529
Jonathan D WassermanDivision of Endocrinology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-7088-8146
Charis EngGenomic Medicine Institute, Lerner Research Institute, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-3693-5145
David MalkinDivision of Haematology and Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-5752-9763
William D FoulkesDepartment of Human Genetics, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-7427-4651
Orli Michaeli *Division of Hematology and Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.ORCID 0000-0002-6097-6457
Andrew J Bauer *Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-3952-881X
Douglas R Stewart *Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Rockville, Maryland.ORCID 0000-0001-8193-1488

Funding

DICER1 and the Pleuropulmonary Blastoma Family Cancer SyndromeR01CA143167 · NCI · CHILDREN'S RESEARCH INSTITUTE · PI HILL, DANA ASHLEY · 2010 to 2020
$3.7M
Detecting DICER1: A global partnership to cure pediatric lung cancerR37CA244940 · NCI · CHILDREN'S HOSPITALS AND CLINICS · PI Kris Ann Pinekenstein Schultz · 2020 to 2026
$2.4M
Children's Minnesota FoundationNational Cancer Institute (NCI)National Cancer Institute (NCI) R01CA143167National Cancer Institute (NCI) R37CA244940National Institute for Health and Care Research (NIHR) NIHR203308NCI NIH HHS R01 CA143167NCI NIH HHS R37 CA244940Pine Tree Apple Classic Fund
6 · The paper itself

Abstract

Phosphate and tensin homolog hamartoma tumor syndrome, DICER1-related tumor predisposition, and tuberous sclerosis complex are rare conditions, which each increases risk for distinct spectra of benign and malignant neoplasms throughout childhood and adulthood. Surveillance considerations for each of these conditions focus on patient and family education, early detection, and multidisciplinary care. In this article, we present updated surveillance recommendations and considerations for children and adolescents with phosphate and tensin homolog hamartoma tumor syndrome, DICER1-related tumor predisposition, and tuberous sclerosis complex and provide suggestions for further research in each of these conditions.

Indexed as

DEAD-box RNA HelicasesGenetic Predisposition to DiseaseHamartoma Syndrome, MultiplePTEN PhosphohydrolaseRibonuclease IIITuberous SclerosisAdolescentChildHumansMutationDEAD-box RNA HelicasesDICER1 protein, humanPTEN PhosphohydrolasePTEN protein, humanRibonuclease III

Identifiers

PMID39540884
PMCPMC11747828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.